Get in touch (813) 875-6600


Morphogenesis has built a broad intellectual property portfolio that includes over 20 issued patents and a number of pending applications in the US and foreign countries. The Company’s intellectual property covers our cancer immunotherapy, rare cell identification and isolation, stem cell growth factor and matched stem cell bank technologies.patents